# PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?

> **NCT02380027** · PHASE3 · COMPLETED · sponsor: **University College, London** · enrollment: 500 (actual)

## Conditions studied

- Prostate Neoplasm

## Interventions

- **DEVICE:** MRI
- **PROCEDURE:** MRI-targeted biopsy
- **PROCEDURE:** TRUS-biopsy

## Key facts

- **NCT ID:** NCT02380027
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2018-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380027, "PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02380027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*